Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
Simone Krebs, Audrey Mauguen, Onur Yıldırım, Vaios Hatzoglou, Jasmine H. Francis, Lauren Schaff, Ingo K. Mellinghoff, Heiko Schöder, Christian Grommes
Topics & Concepts
IbrutinibMedicineLymphomaPositron emission tomographyRadiologyNuclear medicinePET-CTInternal medicineLeukemiaChronic lymphocytic leukemiaCNS Lymphoma Diagnosis and TreatmentLymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research